Micronucleus evaluation in mitogen-stimulated lymphocytes of PUVA treated patients

Creative Commons License

Hamurcu Z., Demirtas H., Ascioglu O., Donmez-Altuntas H., Aktas E.

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, vol.198, no.1, pp.11-21, 2002 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 198 Issue: 1
  • Publication Date: 2002
  • Doi Number: 10.1620/tjem.198.11
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.11-21
  • Erciyes University Affiliated: Yes


PUVA describes the treatment of patients with psoralens plus an exposure to a source of UV light of 320-400 nm (UVA). Contradictory results have been reported on the chromosomal damage of PUVA when assayed by sister chromatid exchange (SCE) method. Micronucleus (MN) test is used to detect both clastogenic (breaking) and aneugenic (abnormal segregation) effect of physical/chemical agents on the chromosomes. No data have been found on the MN formation in the cells of PUVA treated patients. Frequency of micronuclei in 72 hours cultivated/mitogen-stimulated lymphocytes of patients have been evaluated at zero time and after 20, 40, 60 sessions of PUVA treatment. While the beginning MN frequency was similar to0.22% (n = 23), it raised to similar to0.32 (n = 23), similar to0.42 (n = 14) and similar to0.53% (n - 10) corresponding respectively to 20, 40 and 60 sessions. These sessions correspond reciprocally to 54+/-23, 172+/-48, 300+/-61 joules/cm(2) of UVA and 13, 26, 39 mg/kg of 8-metoxypsoralen (8-MOP). While large interindividual. variances were apparent, highly significant differences have been observed between initial MN frequency and after that of the 20, 40 and 60 sessions, (p = 0.000, p = 0.004, p = 0.005, reciprocally, Wilcoxon two-related samples test). The coefficient of correlation between MN frequency and UVA doses starting from zero to 60 sessions of treatment has been found as r = 0.61. This indicates a significant relationship between UVA doses and MN frequencies. However, MN inducibility and synergistic property of 8-MOP with UVA should be taken into account. Gradual MN increase during different sessions of PUVA treatment shows that -once appeared-, a part of MN at least persist in the cells of patients from a few days to a few weeks. Smoking as a confounding factor seems to increase MN frequency (p = 0.053, Mann-Whitney U-test) in the beginning population, taken as the control population. This is the first report on the kinetics of MN formation during different sessions of PUVA treatment. Based on our results, we concluded that PUVA treatment causes a detectable chromosome damaging effect on the relatively profound cells/tissues of its human users. Therapists should be careful with its use, especially on the patients who may be more susceptible to carcinogenesis (e.g. immunosuppressed and/or elderly subjects).